Study of Calcium Absorption in Man:
|
|
|
- Tyler Sherman
- 10 years ago
- Views:
Transcription
1 Study of Calcium Absorption in Man: A Kinetic Analysis and Physiologic Model STANLEY J. BIRGE, WILLAM A. PECK, MoNEs BEIk.AN, and G. DONALD WHEDON From the Metabolic Diseases and Mathematical Research Branches, National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, Bethesda, Maryland and the Department of Medicine, The Jewish Hospital of St. Louis and Washington University School of Medicine, St. Louis, Missouri A B S T R A C T A physical model of calcium absorption was developed from analysis of data obtained on 23 subjects, including 13 patients having a variety of abnormalities of calcium metabolism. The model was tested and found consistent in all subjects studied. This technique provides a quantitative description of the rate of entry of oral dose of 'TCa into the circulation as a function of time by analysis of serum or forearm radioactivity in response to intravenous and oral administration of 'TCa. The kinetics of the absorption process as proposed by the model are characterized by an initial delay phase of min, by a maximal rate of absorption at min after ingestion, and by 95% completion of the absorption within 2i hr. Partial identification of the physiological counterparts of the model was possible by introduction of the isotope at various levels of the gut Although the region of the duodenum was found to have the greatest rate of absorption per unit length in normal subjects, it was least responsive to stimulation by parathyroid hormone and suppression by calcium loading. Furthermore, the response of the gut to parathyroid hormone was delayed, whereas the suppression of absorption by intravenous or oral calcium loading was rapid and dramatic. The implications of these observations are discussed. This work was presented in part at the 1966 annual meeting of The American Federation for Clinical Research. Dr. Birge's present address is Department of Medicine, The Jewish Hospital, St. Louis, Mo Dr. Peck's present address is Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, N. Y Received for publication 15 October 1968 and in revised form 1 April INTRODUCTION The use of tracer techniques has greatly facilitated the study of intestinal absorption of calcium. The fraction of radioactive calcium ('Ca or 'Ca) recovered in the stool after an oral dose of the isotope has provided reasonable estimates of calcium absorption in patients (14). True net calcium absorption has been obtained by correcting for endogenous fecal excretion determined by the fractional dose recovered in the stool after intravenous administration of isotope. More recently this time-consuming and cumbersome approach has been avoided by analysis of the fraction of radioactivity excreted in urine (5, 6) or appearing in the forearm as determined by external monitoring (7) after oral and intravenous administrations of the isotope. This technique is based on the assumption (8) that fractional loss of the absorbed portion of the oral dose is identical with that of the intravenous dose and also permits quantification of the fraction of dose absorbed. The relative rate of appearance of the isotope in the circulation by serial blood samples (4, 9-11) or by external monitoring of the forearm (12) after oral administration alone has been used as a rough and rapid means to estimate relative calcium absorption in various states of altered calcium metabolism. Data obtained by these techniques are inadequate for kinetic analysis of the absorption process. As a result of the limitations of existing techniques, little progress has been made in understanding this fundamental process despite the importance of calcium absorption in numerous disease states. This report presents a technique for the study of cal-- cium absorption through the construction of a physical model that accounts quantitatively for the rate of cal- The Journal of Clinical Investigation Volume
2 cium absorption as a function of time and provides a framework for physiological interpretation of the process. This technique involves the analysis of serum or forearm radioactivity after oral and intravenous administration of '7Ca. METHODS The population studied consisted of 10 normal volunteers between the ages of 21 and 55 yr and 13 patients with a variety of disorders of calcium metabolism including hypoparathyroidism, hyperparathyroidism, idiopathic hypercalcuria, and nontropical sprue. Except for two patients with hypoparathyroidism and one patient with idiopathic hypercalcuria, all subjects were studied on a metabolic ward and consumed diets constant in calcium, phosphorous, and total calories. All subjects were maintained on a constant diet and activity regimen for a minimum of 2 wk before the initiation of the absorption studies. No patient or volunteer was studied while receiving a daily dietary intake that differed by more than 150 mg of calcium from his customary intake as estimated by careful history. On the day of isotope administration, a standard 12 mg calcium meal consisting of cream of wheat, salt-free toast, jelly, and lemonade was given to the subject at 8:00 a.m. after an overnight fast. The meal was supplemented with a desired amount of calcium equivalent to that taken with the regular breakfast on other days, either as calcium lactate added to the lemonade or as calcium gluconate given intravenously over a 2A hr period from 8:00 to 10:30 a.m. Unless otherwise stated, 200 mg of calcium as calcium lactate was used as the supplement. '7Ca with a specific activity of approximately 150 usc/mg was given orally to the subject in 50 cc of skim milk at 10 :30 a.m. Each oral dose of "7Ca was followed in 8-14 days by an intravenous injection of the isotope at the same time of day under identical dietary conditions, the arm or blood being monitored as after oral administration of the isotope. The appearance of the '7Ca in the forearm was monitored with a large volume liquid scintillation 'y-spectrometer (Armac, Packard Inst. Co., Phila., Pa.) by a modification of the technique described by Lutwak and Shapiro (12). Blood activity was determined from serial 3 cc serum samples counted in a low background 'y-ray spectrometer. To ensure exclusion of the decay product 47Sc, a base level of mev was used in both spectrometers. With the Armac, the patient wvas monitored for periods of 3 min over the first 2A hr, then for four consecutive 5-min periods every 40 min for an additional 6-8 hr. The changing background radioactivity was monitored alternately with the forearm radioactivity. The background was obtained with the forearm removed from the counter chamber and the elbow of the flexed arm placed at the entrance of the chamber without otherwise altering the position of the body. As a standard, a known aliquot of the administered radioactivity was diluted to 1 liter and was monitored at hourly intervals in the Armac. Isotope decay and fluctuations in counting efficiency were corrected for by expressing the net arm counts (counts from the arm minus background) or counts from serum obtained within a given 60 min period as a per cent of the standard monitored during the same 60 min period. Finally, the data were expressed as a per cent of the administered dose. With the use of serum radioactivity, 12 blood samples were obtained at intervals sufficiently close to define the response of the administered dose. A known dilution of the administered dose was monitored as above with the low 1706 S. J. Birge, W. A. Peck, M. Berman, and G. D. Whedon background spectrometer, and the data were expressed as a per cent of the administered dose. With the use of the Armac, 4,uc orally or 2,uc intravenously were sufficient to give good counting statistics for counting periods of 3 min. Doses about two and one-half times greater were required to obtain satisfactory statistics on radioactivity in serum. Because of greater facility and lower radiation doses, the Armac was used in most of the studies reported here. In most studies stool was collected for 6-day periods demarcated by fecal dye markers. Radioactivity determinations were made on homogenates of the pooled specimens made up to 1 liter. A standard of identical geometry and the stool sample was monitored with the large volume liquid scintillation spectrometer. Parathyroid hormone used in these studies was kindly prepared by Dr. G. D. Aurbach and Dr. Potts from hormone purified on a Sephadex column (13). Mathematical analysis. Mathematical analysis involved two phases. The initial phase in developing a model for intestinal absorption was the derivation of a function to describe the rate of entry of labeled calcium into the plasma after an oral dose. This function was derived from measurements resulting from a unit of "7Ca injection into the plasma and a unit of "7Ca given orally. The mathematical procedure for this derivation is known as deconvolution, or inverse convolution. The basic formulation of convolution and deconvolution may be described as follows: let the term "response," R (t), be any tracer measurement in the system after some time-dependent input, I(t). In particular, let the response to a single unit injection be W(t). Since, as far as the tracer is concerned, the system is linear 1 with timeindependent rate constants, the response, R(t), to any input, I(t), can be derived in terms of the response to a single injection by the convolution integral (14, 15). R(t) rt = f I(@) W(t-o) do, where 0 is a dummy variable of integration. Using the inverse of this technique it is possible, given the response W (t) of a system to a unit impulse and its response R (t) to an unknown input, to calculate the unknown input. Details of the mathematical formalism for the inverse process (deconvolution) are provided in the literature (14). Several functions for the rate of calcium absorption (rate of TCa into plasma after an oral dose) in various clinical and physiological states are shown in Fig. 1. In this calcium system the input is the intravenous or oral administration of the isotope. The response is the measured radioactivity in the arm (using the Armac) or the blood. Implicit in this method of analysis are the assumptions that (a) there is no difference in the metabolism of tracer calcium between oral and intravenous administration once it enters the plasma, (b) the system remains the same during the two experiments, and (c) the derived plasma input function describes the entry of '7Ca into the circulation from the gastrointestinal tract after oral administration. The second phase in the modeling involves the development of a mechanistic model to explain the characteristics of the derived input function, the entry of "7Ca into plasma after 1'A system is said to be linear if its response to a linear combination of arbitrary time-dependent inputs equals the same linear combination of individual responses. Thus, if the response to input I, is R1, and the response to input I2 is R2, etc., then the response to input (k111 + k2i2 +...) is (k1rl + k2r2+..).
3 oral administration of "7Ca. A compartmental model was employed for this purpose. The deconvolution, compartmental analysis, and data fitting were performed on a digital computer using the SAAM program and the techniques developed by Berman, Shahn, and Weiss (16-18). After numerous attempts a "simplest" universal model, compatible with the results on all patients studied, was derived. A schematic representation of the model is given in Fig. 2. The first segment (A) of the model behaves as a single compartment from which no absorption occurs. Segments B and C of the model represent two separate "delay" sections from which material diffuses out with rate constants Xl and X,. Z represents another compartment-like stage through which the material passes just before it enters the circulation. Operationally the delay segments B and C are each simulated by three compartments in series (Fig. 3). The number of compartments used to simulate delay is determined by the shape of the function R (t) and the degree of resolution required by the data. The values of the rate constants X, from one compartment to the next within each delay segment are set equal to each other and represent the reciprocal mean time of transit per compartment. Thus, the total delay in a segment is 3/1x. In the model the two segments have different delays. Diffusion paths from the delay segments into compartment Z is provided by Xs from each of the compartments within the delay segments to compartment Z. The diffusion coefficients for the two delay segments in the model have different values. In an attempt to correlate elements of the model with the physiology of absorption, 'TCa was administered through a nasogastric tube to a normal volunteer who had constantly been receiving an 800 mg calcium diet; he was given 100 mg of calcium as calcium lactate with a standard breakfast as previously described. Under fluoroscopic control the tube in separate studies was adjusted to empty into the stomach / / H' IYPERPARATHYROID 0.010/ z o z IDIOPATHIC HYPERCALCIURIA 0.00 / / tic0.005 _ / ~// / / ' NONTROPICAL SPRUE TIME (MINUTES) FIGURE 1 Rates of intestinal absorption of calcium (function I(t)) in various clinical and physiological states (averages for each of the groups studied). Functions I(t) represent the rate of absorption of the calcium test dose, expressed as fraction of administered amount per minute, starting with the time of the test dose administration. The model parameter values used in generating these curves are given in Table IV. Study of Calcium Absorption in Man 1707
4 at the cardioesophageal junction, into the second portion of the duodenum, and into the jejunum 4 cm beyond the ligament of Treitz. The '7Ca and 50 mg of carrier calcium as calcium lactate were made up to 50 ml in distilled water and infused at a rate approximating stomach emptying of 5 ml/ min beginning at 2i hr after the standard breakfast. Model parameters were derived from the first study, in which the isotope was administered directly into the stomach. Changes in the model necessary to simulate the data obtained from the latter two studies then were investigated and correlated with the anatomical and physiological differences arising from the administration of the isotope at different points along the intestine. RESULTS Functions I(t) describing rates of absorption per minute expressed as fractions of the administered dose for various clinical and physiological states were illustrated in Fig. 1. The essential characteristics of these functions are: (a) an initial delay of approximately 20 min, (b) a maximal rate of absorption which occurs at min, and (c) completion of significant absorption at 21 hr. In correlating elements of the model with the physiology of absorption, portions of the intestine were excluded by the introduction of the isotope with a nasogastric tube at various points along the small intestine. The calculated absorption of the isotope when delivered directly to the stomach, the second portion of the duodenum, and the jejunum 4 cm distal to the ligament of Treitz was 47%, 40% and 32% respectively. The latter two responses were successfully simulated by an input function feeding into the second and third compartments B CIRCULATION FIGuRE 2 Schematic representation of the calcium absorption model. Its interpretation with respect to physiologic counterparts is as follows: A is the stomach from which calcium is transferred at a rate X, to B without calicum absorption occurring from A. B is a segment of the gut corresponding to the duodenum and first portion of jejunum from which absorption occurs at a rate X,. C is a segment of the gut distal to B from which absorption occurs at a rate Xl and from which calcium passes outside the system. Although only superficially delineated, Z may be attributed in part to the intestinal wall by reflecting the rate of transfer X, from the intestinal wall into the general circulation. See text for details of the physiologic interpretation S. J. Birge, W. A. Peck, M. Berman, and G. D. Whedon C TABLE I Calcium Absorption Determined in the Same Subject under Identical Experimental Conditions Variable model parameters* % ab- Study$ A B C X Y sorbedi * Variable model parameters refer to the X of the components of model designated in Fig. 2 and are expressed as fractional transfer per minute. t The two studies, a month apart, were performed after 415- mg oral loads of calcium lactate given to the same patient constantly taking a diet containing 800 mg of calcium. The per cent absorbed is derived directly by integration of the function I(t). respectively of the first segment at the rate of 10% of the administered dose per min for 10 min. It was necessary, however, in the curve fitting of both studies to introduce an additional compartment to establish a delay of approximately 10 min. The additional compartment is represented in Fig. 2 by compartment Z. Other than the site of entry and the delay, no alteration of model parameters defined by the introduction of isotope into the stomach was necessary. The values for the per cent of calcium absorbed as derived from the model were compared in the same patients with the values derived from the radioactivity recovered in the feces as collected in 6-day pools demarcated by fecal dye markers. The observed fecal radiocalcium was corrected for endogenous fecal excretion by data obtained from the intravenous administration of the isotope. Estimates of absorption based on stool data were consistently higher by 1-10% than estimates from the model (Fig. 4). The reproductibility of the technique in the same subject under identical dietary conditions over an interval of 1 month is illustrated in Table I. The deviation from the mean of the two determinations was 4.4% and is considered to be within normal physiological variation. In the investigation of the various parameters which could possibly influence the rate of absorption of the test dose, it was noted that in addition to the amount of carrier calcium given with the 'Ca, the amount of calcium in a meal 2J hr before the administration of the isotope was also of significance. This effect of calcium loading before the administration of the isotope was studied in a group of healthy volunteers between the ages of 47 and 55 studied while receiving continuously an 800 mg calcium diet. Different calcium loads as calcium lactate were added to the standard 12 mg calcium meal given 2J hr before isotope administration. All sub-
5 FIGURE 3 Calcium absorption model: the form of the solution of I(t) used by the computer program SAAM. Circles represent compartments or components of delay series. The triangle represents the composite function R(t) whkch contains the data obtained from the observed response to the input. Arrows are flow pathways expressed as fractional transfer per minute. The interrupted lines (a, and a,) connecting the triangle R(t) to compartments of W(t) are the fraction of W(t) measured by R(t). The lambdas with identical subscripts are equal. jects were studied with two or more different calcium loads. Per cent absorption was found to decrease as the calcium load increased. The data also suggest that even small loads of calcium (less than 100 mg) significantly decrease per cent calcium absorption 21 hr later (Fig. 5) Ṫhe significance of isotope dilution in the intestinal tract by the oral calcium load in comparison to the effect of an intravenously administered load simulating the absorption from the oral load was investigated in a patient fully adjusted to an 800 mg calcium diet. This equivalent intravenous load (180 mg) was determined from the per cent absorption (54%) of a 330 mg oral calcium load, as determined in a separate study in-which the isotope was given with a 330 mg calcium load after an overnight fast. Furthermore, the intravenous load was given in a rate pattern which simulated the shape of the absorbed oral load as well. as its magnitude. The results (Table II) indicate that there was no significant difference in suppression of the rate of absorption of the test dose by either the oral calcium load or its equivalent given'intravenously. Furthermore, the rates of absorption as delineated by the model were quantitatively similar. The role of parathyroid hormone in regulating calcium absorption was investigated in three patients with postoperative hypoparathyroidism. One of these patients (M.A.) was being treated with 50,000 U of vitamin D2 and consequently had a higher base line level of calcium absorption. 400 U of parathyroid hormone were infused intravenously at a constant rate over a 4 hr period. 'TCa was administered 2j hr after a 250 mg calcium load and at 2 hr (in D.M. and M.A.) and 3 hr (M.K.) after initiation of parathyroid hormone infusion. No apparent stimulation of calcium absorption was observed during a 4-5 hr period after the initiation of the parathyroid hormone infusion (Table III). Maximal reduction of tubular reabsorption of phosphate was observed within this time interval. Serum calcium also increased (although within the limits of error for the technique). Patient D.M. who was not receiving vitamin D was given the same preparation of parathyroid hormone intramuscularly over a 3 wk period. 200 U in a vehicle of 15% gelatin was given twice daily. Urine calcium in- Study of Calcium Absorption in Man 1709
6 creased from an average of 106 to 550 mg/24 hr, and serum calcium increased from an average of 8.1 to 11.5 mg/100 ml. After urine and serum calcium seemed to reach a plateau, the patient was given the oral and intravenous '"Ca. In contrast to the previous observation, intestinal calcium absorption increased twofold to a level comparable with patients with primary hyperparathyroidism (Table III). Table IV summarizes the results obtained from studies of patients with various disorders of calcium metabolism and normal volunteers. DISCUSSION A mathematical model of calcium absorption was developed, and data supporting its physiological interpretation are presented. This analysis provides a quantitative description of the kinetics of calcium absorption and a method for the investigation of factors influencing calcium absorption. The mathematical treatment of the experimental observations made in these studies requires the critical assumption that the physiological conditions which determine the weighting function as defined by the intravenous administration of the isotope are unaltered at the time of the oral administration of the isotope days earlier. This assumption requires that the conditions of the intravenous study with respect to the time of administration, calcium load, and dietary intake by carefully duplicated in the oral administration of the isotope. It is also necesary that the subject be sufficiently adjusted to a given daily dietary calcium intake before the initiation of the two studies. Z10i z %% 81 V) 6( CI 4I 0 0- o.0~~~ 0 0~~e % ABSORPTION BY KINETIC DATA FIGURE 4 Comparison of calcium absorption data obtained by stool analysis with the data obtained from the physiologic model. Calcium absorption was measured by the recovery of "Ca in a 7 day stool collection after the oral administration of the isotope. The per cent of the administered dose retained by the paient was corrected for endogenous fecal excretion. These results represented by the closed circles were compared in the same patient to the results obtained at the same time from the kinetic data represented by the straight line. Each point represents a different patient S. J. Birge, W. A. Peck, M. Berman, and G. D. Whedon I I CALCIUM LOAD(mg) FIGURE 5 The effect on an oral calcium load on calcium absorption. Four patients were studied at two or more different oral calcium loads given 2-i hr before the administration of '7Ca. Calcium load was given as calcium lactate dissolved in lemonade. Except possibly for adjustment to a constant level of calcium intake, these requirements would be eliminated by the simultaneous administration of the intravenous and oral doses by use of two different calcium isotopes. Partial identification of the physiological counterpart to the model was done by evaluating the response to the introduction of the isotope by tube directly into the gut at various levels. The response resulting from exclusion of the gut proximal to the second portion of the duodenum and proximal to the ligament of Treitz was simulated in the model by altering only the site of entry of the input in the model. Despite the exclusion of compartment A by the input, a delay of approximately 10 min was still needed in order to fit the curves of the simulated data to the curves of the observed experimental data. As the model was originally constructed, the entire delay (20 min) was described by the first compartment (A), since one could not distinguish between an early and late delay. These studies therefore serve to delineate some delay at A, TABLE I I Comparison of the Effect of an Oral and Intravenous Load of Calcium on Subsequent Calcium Absorption Variable model parameters* % ab- Study$ A B C X Y sorbed 330 mg, oral mg, i.v * The model parameters refer to those designated in Fig Absorption of calcium was studied in the same patient after an oral load of 330 mg and then after an equivalent intravenous load of 180 mg. The equivalent intravenous dose of calcium was determined from the amount of calcium absorbed from the 330 mg of calcium given orally.
7 TABLE III The Influence of Parathyroid Hormone on Calcium Absorption* M. K. M.A. D. M. Control PTH, i.v. Control PTH, i.v. Control PTH, i.v. PTH, i.m. % absorption Serum calcium, mg/100 ml % TRPt * Three patients with postoperative hypoparathyroidism were studied after the standard low calcium meal during a 4 hr parathyroid hormone infusion of 400 U. M. K. and M. A. were maintained on 25,000-50,000 U of vitamin D per day respectively throughout the studies. D. M. was maintained on supplemental calcium alone without vitamin D. See text for detail of protocol. t Tubular reabsorption of phosphate. and some at Z, a point beyond the level of intubation. Since no other changes in the model were necessary to fit these studies, one can propose that the portion of the model proximal to the input describes that portion of the gut excluded by the nasogastric tube. The delay at A, therefore, is postulated to be the rate of transit from a region of nonabsorption, the stomach, into the first portion of the duodenum. The delay Z was added to the model and postulated to reflect in part the transit time across the intestinal mucosa to the general circulation. Although not measured, we have assumed that a delay of similar magnitude is also operational in the last series segment of the model. In the physiologic interpretation of the model, the assumption is made that the kinetics of the "7Ca introduced into the circulation through a peripheral vein are not significantly altered by the introduction of the isotope through the portal circulation. It is reasonable that there is in fact a small delay in the kinetics of the isotope imposed by the hepatic circulation which would be manifested to a lesser extent in the kinetics of the isotope introduced into the perihperal circulation. This delay if present would appear in the absorption model and is probably imbedded in the delay at Z (Fig. 2). Since the hemodynamics of such a delay are relatively constant and independent of calcium metabolism, the interpretation of the model for other subjects would be similar. As new information from perturbations of the absorption process is obtained, further refinements of the model may be possible. The proposed model is not unique, so that a number of different combinations of components and connections between components are possible. It is the simplest mathematical construct that we could devise from the data and that is also consistent with general concepts of intestinal absorption. In general, the model as presented consists of three segments in series, with diffusion paths or absorption from the second and third segments. Although some physiological identification of the model components may be possible, there need not be a simple one to one correlation between an element of the model and a discrete unit of intestinal anatomy and(or) physiology. Thus for example, it is unlikely that rate of calcium absorption along the gut is discontinuous occurring TABLE IV Studies of Calcium Absorption in Normal Subjects and Patients with Disorders of Calcium Metabolism Model parametersl % administered dose absorbedi Number of Calcium patients Diagnosis intake* A B C X Y B C Total 6 Normal control, Ca load < 100 mg ± ±5.4 4 Normal control, Ca load > 100 mg ± ± ±2.4 2 Nontropical sprue ± ± ±2.2 3 Hyperparathyroidism ± ± Hypoparathyroidism ± ± ±1.0 4 Idiopathic hypercalciuria ± ± ±4.3 * Daily calcium intake in milligrams. Model parameters refer to those in Fig. 2 and are expressed as the mean of the designated patient group. Derived absorption in segments B and C and total absorption are expressed as the mean ±se for the patient groups. Study of Calcium Absorption in Man 1711
8 at only two rates. It is of significance, however, that all attempts to simulate the absorption function with less than two independent rates were unsuccessful. The mathematical approach presented here need not be restricted to the study of calcium absorption. Segre (19) has succefully studied the kinetics of intestinal absorption of a variety of drugs using a similar mathematical approach. Since absorption rate actually adepends not only on the magnitude of the calcium preload but probably also on the time interval between it and the time of administration of tracer, it is quite likely that the rate "constants" of the model are time and(or) concentration dependent. There is no way to resolve this possible time dependence from the data obtained in the presented experiments. The present model may require modification if time and(or) concentration dependence of parameters are introduced. Determination of the percent absorption of the administered isotope by the model was consistently 1-10% lower but in good agreement with the values obtained by methods based en recovery of radiocalcium in the stool. The direction of this difference probably can be accounted for by minor losses of stool in collecting and processing and by continued (or delayed) excretion of the isotope beyond the first 6 days of collection (20). We cannot exclude, however, the possibility that part of this difference is due to a physiological mechanism not included in our assumptions such as, for example, an enterohepatic cycling of calcium. Further studies are necessary in this area. Assuming the physiological interpretation of the model to be correct, then in normal subjects studied while receiving an 800 mg calcium diet and after a calcium load of less than 150 mg, the rate of absorption by the duodenum is approximately three times that of the remainder of the gut. However, if the rate of absorption is expressed per unit length of gut, and if the transit time through that portion of the gut involved in calcium transport is constant, then the rate of absorption per unit length by the duodenum is approximately nine times that of the remaining gut. In vitro studies with rat intestine (21) have demonstrated that maximal absorption of calcium occurs in the duodenum by an active transport process. Kimberg, Schachter, and Schenker (22) have also demonstrated that although active transport occurs predominantly in the duodenum of the rat, the jejunum and ileum were also capable of active transport under conditions of low calcium intake for a period of days. The observations reported here would suggest that a similar but more sensitive mechanism applies in man. Not only does significant calcium transport occur distal to the duodenum in human subjects, but this region, as illustrated in Table IV, shows the greatest response to calcium loading and in hyperparathyroidism may account for 75% of the total absorption. These data suggest that the gut distal to the duodenum is more sensitive to factors controlling calcium absorption under normal physiological conditions. Regulation of calcium absorption, therefore, is probably mediated primarily through a portion of the gut distal to the duodenum. The suppression of absorption by calcium loading 24 hr before the administration of the isotope in the absence of significant isotope dilution within the lumen of the gut suggests that increased concentration of extracellular calcium suppresses intestinal mucosal transport (a) directly or (b) indirectly through a hormonal feedback mechanism such as the parathyroid axis. The action of parathyroid hormone on intestinal transport of calcium was investigated and was found to have no stimulatory effect during the first 4-5 hr after initiation of the hormone infusion. In contrast, the maximal effect on renal phosphate transport as measured by the per cent of tubular reabsorption of phosphate (TRP) occurred during the 3rd and 4th hr after the initiation of the infusion. The absence of stimulation and (in M.A.) suppression of calcium absorption acutely may in part be related to an elevation of plasma calcium by action of parathyroid hormone peripheral to the gut. A stimulatory effect on absorption, however, was observed during prolonged intramuscular administration of comparable doses of hormone despite significant hypercalcemia. Thus, the action of parathyroid hormone on the gut to increase calcium absorption is delayed in its onset. If regulation of calcium absorption by parathyroid hormone were dependent on de novo synthesis of a protein this might account for the observed delay in onset of action. It is even possible that the action of parathyroid hormone on the intestine may be effected through synthesis of a calcium-binding protein, similar to that described by Wasserman and Taylor (23), which could be involved in active transport of calcium across, intestinal mucosa. The rapid and dramatic suppression of calcium absorption in response to a calcium load as compared with the delayed stimulation of absorption by parathyroid hormone suggests the possibility that rapid or fine regulation of absorption is mediated through a direct effect of circulating calcium on mucosal transport, and coarse regulation is mediated through the action of para-- thyroid hormone on intestinal transport. Data presented in Table IV suggest that discrimination of abnormally enhanced intestinal absorption of calcium from normal is improved by partially suppressing calcium absorption in the normal subject with a calcium load. This suppression had the effect of narrowing the range for normal subjects from 25-60% to 1712 S. J. Birge, W. A. Peck, M. Berman, and G. D. Whedon
9 25-40%. Thus, pathological hyperabsorption of calicum in this series of patients was clearly delineated both quantitatively and qualitatively from intestinal absorption of calcium in normal subjects. ACKNOWLEDGMENT This work was supported in part by grant AM from the National Institute of Arthritis and Metabolic Diseases. REFERENCES 1. Bronner, F., R. S. Harris, C. J. Maletskos, and C. E. Benda Studies in calcium metabolism. Effect of food phytates on calcium" uptake in children on lowcalcium breakfasts. J. Nutr. 54: Blau, M., H. Spencer, J. Swernov, and L. Laszlo Utilization and intestinal excretion of calcium in man. Science (Washington). 120: DeGrazia, J. A., and C. Rich Studies of intestinal absorption of calcium" in man. Metab. (Clin. Exp.) 13: Avioli, L. V., J. E. McDonald, R. A. Singer, and P. H. Henneman A new oral isotopic test of calcium absorption. J. Clin. Invest. 44: Bronner, F Experimental studies of calcium absorption in man. Bibi. Nutr. Dieta. 3: DeGrazia, J. A., P. Ivanovich, H. Fellows, and C. Rich A double isotope method for measurement of intestinal absorption of calcium in man. J. Lab. Clin. Med. 66: Curtis, F. K., H. Fellows, and C. Rich Estimation of human calcium absorption by external radioisotope counting. J. Lab. Clin. Med. 69: Garner, R. J., H. G. Jones, and B. F. Sansom Fission products and the dairy cow. II. Some aspects of the metabolism of the alkaline-earth elements calcium, strontium and barium. Biochem. J. 76: Samachson, J Plasma values after oral "calcium and 'strontium as an index of absorption. Clin. Sci. 25: Jaworski, Z. F., E. M. Brown, S. Fedoruk, and H. Seitz A method for the study of calcium absorption by the human gut using a standard dose of calcium labeled with calcium'7. N. Engl. J. Med. 269: Caniggia, A., C. Gennari, V. Bianchi, and R. Guideri Intestinal absorption of 'Ca in senile osteoporosis. Acta Med. Scand. 173: Lutwak, L., and J. R. Shapiro Calcium absorption in man: based on large volume liquid scintillation counter studies. Science (Washington). 144: Aurbach, G. D., and J. T. Potts, Jr Partition of parathyroid hormone on Sephadex G100. Endocrinology. 75: Rescigno, A., and G. Segre Drug and Tracer Kinetics. Blaisdell Publishing Co., Div. of Ginn & Co, Waltham, Mass. 15. Brownell, G. L., M. Berman, and J. S. Robertson Nomenclature for tracer kinetics. Int. J. Appl. Radiat. Isotop. 19: Berman, M., E. Shahn, and M. F. Weiss The routine fitting of kinetic data to models: a mathematical formalism of digital computers. Biophys. J. 2: Berman, M., M. F. Weiss, and E. Shahn Some formal approaches to the analysis of kinetic data in terms of linear compartmental systems. Biophys. J. 2: Berman, M Compartmental analysis in kinetics. In Computers in Biomedical Research. R. W. Stacy and B. D. Waxman, editors. Academic Press Inc., New York. 2: Segre, G Compartmental models in the analysis of intestinal absorption. Protoplasma. 63: Kinney, V. R., W. N. Tauxe, and W. H. Dearing Isotopic tracer studies of intestinal calcium absorption. J. Lab. Clin. Med. 66: Schachter, D., E. B. Dowdle, and H. Schenker Accumulation of Ca" by slices of -the small intestine. Amer. J. Physiol. 198: Kimberg, D. V., D. Schachter, and H. Schenker Active transport of calcium by intestine: effects of dietary calcium. Amer. J. Physiol. 200: Wasserman, R. H., and A. N. Taylor Vitamin Doinduced calcium-binding protein in chick intestinal mucosa. Science (Washington). 152: 791. Study of Calcium Absorption in Man 1713
PHOSPHATE-SANDOZ Tablets (High dose phosphate supplement)
1 PHOSPHATE-SANDOZ Tablets (High dose phosphate supplement) PHOSPHATE-SANDOZ PHOSPHATE-SANDOZ Tablets are a high dose phosphate supplement containing sodium phosphate monobasic. The CAS registry number
Guidance for Industry
Guidance for Industry Food-Effect Bioavailability and Fed Bioequivalence Studies U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)
Pseudohypoparathyroidism: A Variation on the Theme of Hypoparathyroidism
Pseudohypoparathyroidism: A Variation on the Theme of Hypoparathyroidism Amanda Tencza MS IV 1 and Michael A. Levine, MD 2 1 Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Absorption of Drugs. Transport of a drug from the GI tract
Absorption of Drugs Absorption is the transfer of a drug from its site of administration to the bloodstream. The rate and efficiency of absorption depend on the route of administration. For IV delivery,
Nursing 113. Pharmacology Principles
Nursing 113 Pharmacology Principles 1. The study of how drugs enter the body, reach the site of action, and are removed from the body is called a. pharmacotherapeutics b. pharmacology c. pharmacodynamics
Drug Excretion. Renal Drug Clearance. Drug Clearance and Half-Life. Glomerular Filtration II. Glomerular Filtration I. Drug Excretion and Clearance
t/.drugexcretion AINTRAVENOUSDOSE 36848765430TIME(hours) t/ Drug Excretion Dr. Robert G. Lamb Professor Pharmacology & Toxicology Drug Excretion and Clearance Drug Excretion: is the movement of drug from
The Rate and Extent of Calcium Bioavailability from Two Oral Dosage Forms in Rats
Gen. Physiol. Biophys. (1985), 4, 531-536 531 The Rate and Extent of Calcium Bioavailability from Two Oral Dosage Forms in Rats M. ĎURISOVÁ 1, T. TRNOVEC 1, Š. BEZEK 1, Z. KÁLLAY 1 and M. ZEMÁNEK 2 1 Institute
ACTIVE-B12 EIA. the next level of B12 testing
ACTIVE-B12 EIA the next level of B12 testing Vitamin B12 an essential nutrient Vitamin B12 is an essential nutrient (can only be obtained from the diet) and is a vital component in many cellular functions
Parathyroid hormone (serum, plasma)
Parathyroid hormone (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Parathyroid hormone (PTH) 1.2 Alternative names Parathormone 1.3 NMLC code 1.4 Description of analyte PTH is an
Teriflunomide is the active metabolite of Leflunomide, a drug employed since 1994 for the treatment of rheumatoid arthritis (Baselt, 2011).
Page 1 of 10 ANALYTE NAME AND STRUCTURE TERIFLUNOMIDE Teriflunomide TRADE NAME Aubagio CATEGORY Antimetabolite TEST CODE PURPOSE Therapeutic Drug Monitoring GENERAL RELEVANCY BACKGROUND sclerosis. The
Sweet-taste receptors, glucose absorption and insulin release: Are LCS nutritionally active?
Sweet-taste receptors, glucose absorption and insulin release: Are LCS nutritionally active? Samuel V. Molinary, Ph.D. Consultant, Scientific & Regulatory Affairs ILSI/NA April 6, 2011 Washington, DC Why
GP Guidance: Management of nutrition following bariatric surgery
GP Guidance: Management of nutrition following bariatric surgery Introduction Patients who are morbidly obese will have struggled with their weight for many years before going forward for bariatric surgery.
BULLETIN. Slovak Republic Ministry of Health
BULLETIN Slovak Republic Ministry of Health Part 51-53 November 13, 2009 No. 57 CONTENTS: 52. Slovak Republic Ministry of Health Guidelines for the Diagnosis of Glucocorticoidinduced Osteoporosis 52. Slovak
Vitamin D (serum, plasma)
Vitamin D (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Vitamin D 1.2 Alternative names The term vitamin D covers a group of closely related naturally occurring lipid soluble compounds
THE EFFECT OF SODIUM CHLORIDE ON THE GLUCOSE TOLERANCE OF THE DIABETIC RAT*
THE EFFECT OF SODIUM CHLORIDE ON THE GLUCOSE TOLERANCE OF THE DIABETIC RAT* BY JAMES M. ORTEN AND HENRY B. DEVLINt (From the Deparkment of Physiological Chemistry, Wayne University College of Medicine,
A Peak at PK An Introduction to Pharmacokinetics
Paper IS05 A Peak at PK An Introduction to Pharmacokinetics Hannah Twitchett, Roche Products Ltd, Welwyn Garden City, UK Paul Grimsey, Roche Products Ltd, Welwyn Garden City, UK ABSTRACT The aim of this
Questions and Answers for Health Care Providers: Renal Dosing and Administration Recommendations for Peramivir IV
Questions and Answers for Health Care Providers: Renal Dosing and Administration Recommendations for Peramivir IV The purpose of this document is to provide additional clarification to the existing information
LECTURE 1 RENAL FUNCTION
LECTURE 1 RENAL FUNCTION Components of the Urinary System 2 Kidneys 2 Ureters Bladder Urethra Refer to Renal System Vocabulary in your notes Figure 2-1,page10 Kidney Composition Cortex Outer region Contains
OUTCOMES BASED LEARNING MATRIX
OUTCOMES BASED LEARNING MATRIX Course: BIOL 206 Vertebrate Anatomy and Physiology II Department: Biology Course Description: This is the second part of an introductory course sequence in the comparative
D. Vitamin D. 1. Two main forms; vitamin D2 and D3
D. Vitamin D. Two main forms; vitamin D2 and D3 H H D3 - Cholecalciferol D2 - Ergocalciferol Technically, vitamin D is not a vitamin. It is the name given to a group of fat-soluble prohormones (substances
Treating Thyroid Cancer using I-131 Maximum Tolerable Dose Method
Treating Thyroid Cancer using I-131 Maximum Tolerable Dose Method Christopher Martel, M.Sc., CHP Lisa Thornhill,, NRRPT, RT(NM) Boston University Medical Center Thyroid Carcinoma New cases and deaths in
Diabetes mellitus. Lecture Outline
Diabetes mellitus Lecture Outline I. Diagnosis II. Epidemiology III. Causes of diabetes IV. Health Problems and Diabetes V. Treating Diabetes VI. Physical activity and diabetes 1 Diabetes Disorder characterized
RATE OF EXCRETION OF N 15 AFTER FEEDING N16-LABELED /-ASPARTIC ACID IN MAN BY HSIEN WU AND SELMA E. SNYDERMAN
RATE OF EXCRETION OF N 15 AFTER FEEDING N16-LABELED /-ASPARTIC ACID IN MAN BY HSIEN WU AND SELMA E. SNYDERMAN (From the Biochemistry Department, Medical College of Alabama, Birmingham, and the Department
Calcium and Vitamin D: Important at Every Age
Calcium and Vitamin D: Important at Every Age National Institutes of Health Osteoporosis and Related Bone Diseases ~ National Resource Center 2 AMS Circle Bethesda, MD 20892-3676 Tel: (800) 624-BONE or
IV solutions may be given either as a bolus dose or infused slowly through a vein into the plasma at a constant or zero-order rate.
د.شيماء Biopharmaceutics INTRAVENOUS INFUSION: IV solutions may be given either as a bolus dose or infused slowly through a vein into the plasma at a constant or zero-order rate. The main advantage for
Dietary Fat Supplements and Body Condition: Does Fatty Acid Profile Matter? James K. Drackley, Professor of Animal Sciences
Dietary Fat Supplements and Body Condition: Does Fatty Acid Profile Matter? James K. Drackley, Professor of Animal Sciences Does Fatty Acid Profile Matter? How does the balance of the major energy-related
Biokinetic model of americium in the beagle dog. Salt Lake City, UT 84108-1218 (U.S.A.)
Biokinetic model of americium in the beagle dog A. Luciani 1, E. Polig 2, R. D. Lloyd 3, S. C. Miller 3 1 ENEA Radiation Protection Institute via dei Colli, 16 4136 Bologna, (Italy) 2 Forschungszentrum
Homeostatic Model Assessment (HOMA)
Homeostatic Model Assessment (HOMA) Historically, insulin resistance (IR) was measured with an invasive test called a euglycemic clamp test. Basically it s a test to measure how much insulin a person needs
ELECTROLYTE SOLUTIONS (Continued)
ELECTROLYTE SOLUTIONS (Continued) Osmolarity Osmotic pressure is an important biologic parameter which involves diffusion of solutes or the transfer of fluids through semi permeable membranes. Per US Pharmacopeia,
Select the one that is the best answer:
MQ Kidney 1 Select the one that is the best answer: 1) n increase in the concentration of plasma potassium causes increase in: a) release of renin b) secretion of aldosterone c) secretion of H d) release
Vitamin D Deficiency and Thyroid Disease. Theodore C. Friedman, M.D., Ph.D.
Vitamin D Deficiency and Thyroid Disease Theodore C. Friedman, M.D., Ph.D. Vitamin D deficiency and thyroid diseases Vitamin D is an important vitamin that not only regulates calcium, but also has many
HYPERCALCEMIA/HYPERCALCIURIA IN WILLIAMS SYNDROME
HYPERCALCEMIA/HYPERCALCIURIA IN WILLIAMS SYNDROME WHAT IS CALCIUM AND WHY IS IT IMPORTANT? Calcium is an important mineral for building teeth and bones and in chemical reactions, such as those that cause
jejunal and ileal calcium-binding protein and on plasma calcium
Animals Two Effect of vitamin D or calcium deficiency on duodenal, jejunal and ileal calciumbinding protein and on plasma calcium and 25hydroxycholecalciferol levels in the growing pig Monique THOMASSET,
Hypoglycemia (Technician-Paramedic) Protocol revised October 2008
Hypoglycemia (Technician-Paramedic) Protocol revised October 2008 Preamble Prolonged hypoglycemia may result in serious neurologic complications and death. Glucose and glucagon can be administered to correct
Dietary Composition for Weight Loss and Weight Loss Maintenance
Dietary Composition for Weight Loss and Weight Loss Maintenance Bridget M. Hron, MD Instructor in Pediatrics, Harvard Medical School Staff Physician in Gastroenterology & Nutrition and New Balance Foundation
GLUCOSE HOMEOSTASIS-II: An Overview
GLUCOSE HOMEOSTASIS-II: An Overview University of Papua New Guinea School of Medicine & Health Sciences, Division of Basic Medical Sciences Discipline of Biochemistry & Molecular Biology, M Med Part I
Technical Report. Automatic Identification and Semi-quantitative Analysis of Psychotropic Drugs in Serum Using GC/MS Forensic Toxicological Database
C146-E175A Technical Report Automatic Identification and Semi-quantitative Analysis of Psychotropic Drugs in Serum Using GC/MS Forensic Toxicological Database Hitoshi Tsuchihashi 1 Abstract: A sample consisting
Chapter 25: Metabolism and Nutrition
Chapter 25: Metabolism and Nutrition Chapter Objectives INTRODUCTION 1. Generalize the way in which nutrients are processed through the three major metabolic fates in order to perform various energetic
Public Assessment Report Scientific discussion. Tenofovir disoproxil Teva (tenofovir disoproxil) SE/H/1432/01/DC
Public Assessment Report Scientific discussion Tenofovir disoproxil Teva (tenofovir disoproxil) SE/H/1432/01/DC This module reflects the scientific discussion for the approval of Tenofovir disoproxil Teva.
Is Chocolate Milk the answer?
Is Chocolate Milk the answer? Is Chocolate Milk the answer? Karp, J.R. et al. Chocolate Milks as a Post-Exercise Recovery Aid, Int. J of Sports Ntr. 16:78-91, 2006. PROS Study focused on trained athletes
INSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT?
INSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT? MARTHA M. BRINSKO, MSN, ANP-BC CHARLOTTE COMMUNITY HEALTH CLINIC CHARLOTTE, NC Diagnosed and undiagnosed diabetes in the United
PHAR 7633 Chapter 19 Multi-Compartment Pharmacokinetic Models
Student Objectives for this Chapter PHAR 7633 Chapter 19 Multi-Compartment Pharmacokinetic Models To draw the scheme and write the differential equations appropriate to a multi-compartment pharmacokinetic
OSTEOPOROSIS REHABILITATION PROGRAM
OSTEOPOROSIS REHABILITATION PROGRAM Tricia Orme, R.N. BSc(N) Mary Pack Arthritis Program Victoria i Arthritis i Centre Objectives Participants will gain an understanding of what Osteoporosis is and how
Forage Crises? Extending Forages and Use of Non-forage Fiber Sources. Introduction
Forage Crises? Extending Forages and Use of Non-forage Fiber Sources Mike Allen and Jennifer Voelker Michigan State University Dept. of Animal Science Introduction Forage availability is sometimes limited
EFFIMET 1000 XR Metformin Hydrochloride extended release tablet
BRAND NAME: Effimet XR. THERAPEUTIC CATEGORY: Anti-Diabetic PHARMACOLOGIC CLASS: Biguanides EFFIMET 1000 XR Metformin Hydrochloride extended release tablet COMPOSITION AND PRESENTATION Composition Each
A] Calcium. Absorption is interfered with by: Phytic acid of cereal seeds and bran. Oxalic acid and soluble oxalates of some vegetables and fruits.
Food Constituents [continued] 6- Essential elements Diet provides a number of inorganic elements that are needed for: Normal functioning of vital processes of the body. Formation and maintenance of bone
Vitamin D Deficiency and Thyroid Disease. Theodore C. Friedman, M.D., Ph.D.
Vitamin D Deficiency and Thyroid Disease Theodore C. Friedman, M.D., Ph.D. Vitamin D deficiency and thyroid diseases Vitamin D is an important vitamin that not only regulates calcium, but also has many
NHRMC General Surgery Specialists. Minimally Invasive Gastrointestinal Surgery Phone: 910-662-9300 Fax: 910-662-9303
Minimally Invasive Gastrointestinal Surgery Phone: 910-662-9300 Fax: 910-662-9303 W. Borden Hooks III, MD 1725 New Hanover Medical Park Drive Wilmington, NC 28403 Thank you for choosing NHRMC General Surgery
INSULIN PRODUCTS. Jack DeRuiter
INSULIN PRODUCTS Jack DeRuiter The number and types of insulin preparations available in the United States is constantly changing, thus students should refer to recent drug resources for a current list
VITAMIN C AND INFECTIOUS DISEASE: A REVIEW OF THE LITERATURE AND THE RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE STUDY OVER 8 YEARS
39 Chapter 3 VITAMIN C AND INFECTIOUS DISEASE: A REVIEW OF THE LITERATURE AND THE RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE STUDY OVER 8 YEARS Maxine Briggs TABLE OF CONTENTS I. Review of the
Digestive System Functions
Digestive System Functions A. Gastrointestinal Processes 1. Ingestion: placing food in mouth (voluntary) 2. Propulsion: moving food through GI tract a. Peristalsis: alternating waves of contraction and
Course Curriculum for Master Degree in Food Science and Technology/ Department of Nutrition and Food Technology
Course Curriculum for Master Degree in Food Science and Technology/ Department of Nutrition and Food Technology The Master Degree in Food Science and Technology / Department of Nutrition and Food Technology,
Insulin s Effects on Testosterone, Growth Hormone and IGF I Following Resistance Training
Insulin s Effects on Testosterone, Growth Hormone and IGF I Following Resistance Training By: Jason Dudley Summary Nutrition supplements with a combination of carbohydrate and protein (with a ratio of
glucose and fatty acids to raise your blood sugar levels.
Endocrine & Cell Communication Part IV: Maintaining Balance (Homeostasis) TEACHER NOTES needs coding 1 Endocrine & Cell Communication Part IV: Maintaining Balance (Homeostasis) 2 AP Biology Curriculum
Gastrointestinal problems in children with Down's syndrome
Gastrointestinal problems in children with Down's syndrome by Dr Liz Marder This article was written for parents for the Down s Syndrome Association newsletter and is reproduced here with the permission
THE DIGESTIVE SYSTEM
THE DIGESTIVE SYSTEM What is digestion? Digestion is the process of breaking down food so that it's small enough to be absorbed and used by the body for energy or in other bodily functions. Digestion involves
Radioactive iodine treatment for thyroid cancer
Radioactive iodine treatment for thyroid cancer This information is an extract from the booklet, Understanding thyroid cancer. You may find the full booklet helpful. We can send you a copy free see page
Refeeding syndrome in anorexia nervosa
ESPEN Congress Barcelona 2012 Is there a role for nutrition in psychiatric disorders? Refeeding syndrome in anorexia nervosa V. Haas (Germany) ESPEN - 2012 - Barcelona The refeeding syndrome in Anorexia
TOTAL PROTEIN FIBRINOGEN
UNIT: Proteins 16tproteins.wpd Task Determination of Total Protein, Albumin and Globulins Objectives Upon completion of this exercise, the student will be able to: 1. Explain the ratio of albumin and globulin
Medical Physiology Z.H.Al-Zubaydi
Lec.13 Medical Physiology Z.H.Al-Zubaydi Functions of the Digestive System The major functions of the digestive tract include the following six processes, summarized in Figure 1: 1. Ingestion Food must
Summary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT ACEGON, 50 microgram/ml, solution for injection for cattle. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active
Cystic fibrosis and bone health
Cystic fibrosis and bone health Factsheet March 2013 Cystic fibrosis and bone health Introduction As we get older our bones become thinner and weaker, and may become more susceptible to fracture. However
Nutrient Reference Values for Australia and New Zealand
Nutrient Reference Values for Australia and New Zealand Questions and Answers 1. What are Nutrient Reference Values? The Nutrient Reference Values outline the levels of intake of essential nutrients considered,
Overview of Dissolution for BA/BE
Biopharmaceutics Classification System based on Solubility/Permeability Biowaivers for BCS I Drugs Discussion of BCS III Drugs Models establishing in vivo-in vitro Correlations (IVIVC Levels A-C) 1 Biopharmaceutics
The digestive system eliminated waste from the digestive tract. But we also need a way to eliminate waste from the rest of the body.
Outline Urinary System Urinary System and Excretion Bio105 Lecture 20 Chapter 16 I. Function II. Organs of the urinary system A. Kidneys 1. Function 2. Structure III. Disorders of the urinary system 1
Overview of Bariatric Surgery
Overview of Bariatric Surgery To better understand how weight loss surgery works, it is helpful to know how the normal digestive process works. As food moves along the digestive tract, special digestive
14/11/2014. Copper supply affects growth performance and health in growing pigs. Outline. Copper as essential trace elements
Copper supply affects growth performance and health in growing pigs Themamiddag 4 november 2014 Outline Introduction Copper as essential trace element Paul Bikker, Jurgen van Baal, Roselinde Goselink Presence:
Calcium (serum, plasma, blood)
Calcium (serum, plasma, blood) 1 Name and description of analyte 1.1 Name of analyte Calcium (total in serum, plasma, ionised in blood (see 2.1 (2)). 1.2 Alternative names None 1.3 NMLC code 1.4 Description
Regulation of Metabolism. By Dr. Carmen Rexach Physiology Mt San Antonio College
Regulation of Metabolism By Dr. Carmen Rexach Physiology Mt San Antonio College Energy Constant need in living cells Measured in kcal carbohydrates and proteins = 4kcal/g Fats = 9kcal/g Most diets are
Colocutaneous Fistula. Disclosures
Colocutaneous Fistula Madhulika G. Varma MD Associate Professor Chief, Colorectal Surgery University of California, San Francisco Honoraria Applied Medical Covidien Disclosures 1 Colocutaneous Fistula
Review Group: Mental Health Operational Medicines Management Group. Signature Signature Signature. Review Date: December 2014
Mental Health NHS Grampian Mental Health Service Staff Guidance For The Prescribing Of Vitamin Supplementation During In-Patient Admission (Mental Health) For Alcohol Withdrawal Co-ordinators: Consultant
Nutrition Management After Bariatric Surgery
Nutrition Management After Bariatric Surgery Federal Bureau of Prisons Clinical Practice Guidelines October 2013 Clinical guidelines are made available to the public for informational purposes only. The
Oral Zinc Supplementation as an Adjunct Therapy in the Management of Hepatic Encephalopathy: A Randomized Controlled Trial
Oral Zinc Supplementation as an Adjunct Therapy in the Management of Hepatic Encephalopathy: A Randomized Controlled Trial Marcus R. Pereira A. Study Purpose Hepatic encephalopathy is a common complication
Gastrointestinal Bleeding
Gastrointestinal Bleeding Introduction Gastrointestinal bleeding is a symptom of many diseases rather than a disease itself. A number of different conditions can cause gastrointestinal bleeding. Some causes
Liver Function Essay
Liver Function Essay Name: Quindoline Ntui Date: April 20, 2009 Professor: Dr. Danil Hammoudi Class: Anatomy and Physiology 2 Liver function The human body consist of many highly organize part working
Liver, Gallbladder, Exocrine Pancreas KNH 406
Liver, Gallbladder, Exocrine Pancreas KNH 406 2007 Thomson - Wadsworth LIVER Anatomy - functions With disease blood flow becomes obstructed Bile All bile drains into common hepatic duct Liver Bile complex
Skeletal. Parathyroid hormone (PTH) 1 2012-04-04. Analyte Information
Skeletal Parathyroid hormone (PTH) Analyte Information 1 2012-04-04 Parathyroid hormone (PTH) Introduction PTH together with 1,25-dihydroxyvitamin D are the primary hormones regulating bone and mineral
Eating, pooping, and peeing THE DIGESTIVE SYSTEM
THE DIGESTIVE SYSTEM Ingested food is not technically in the body until it is absorbed so it needs to be: Mechanically and chemically reduced Transported by the blood to the cells Large portions are not
Surgical Treatment of Obesity: A Surgeon s View
Surgical Treatment of Obesity: A Surgeon s View Jenny J. Choi, MD Director of Bariatrics Associate Director of Clinical Affairs Assistant Professor of Surgery Albert Einstein School of Medicine Montefiore
PHARMACOLOGICAL PROPERTIES
ANTİ-FOSFAT ca 700 mg Film Tablet COMPOSITION 1 film tablet contains 700 mg Calcium acetate, as an active ingredient. Excipients are Microcrystalline cellulose, Povidone K30, Crosspovidone, Magnesium stearate,
Albumin (serum, plasma)
Albumin (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Albumin (plasma or serum) 1.2 Alternative names None (note that albumen is a protein found in avian eggs) 1.3 NLMC code 1.4
NUCLEAR MEDICINE TECHNOLOGY CERTIFICATE APPLICATION INSTRUCTIONS
State of California Health and Human Services Agency California Department of Public Health Radiologic Health Branch NUCLEAR MEDICINE TECHNOLOGY CERTIFICATE APPLICATION INSTRUCTIONS The State of California
STUDY PLAN FOR THE CERTIFICATE OF THE HIGHER SPECIALIZATION IN ( Diagnostic Radiology)
STUDY PLAN FOR THE CERTIFICATE OF THE HIGHER SPECIALIZATION IN ( Diagnostic Radiology) plan number :15/11/97/NT I-GENERAL RULES AND CONDITIONS: 1- This plan conforms to the regulations of granting the
Grouping to Increase Milk Yield and Decrease Feed Costs
61 Grouping to Increase Milk Yield and Decrease Feed Costs Michael S. Allen 1 Department of Animal Science Michigan State University Abstract There are many advantages of grouping cows to optimize their
FACT SHEET TESTETROL, A NOVEL ORALLY BIOACTIVE ANDROGEN
FACT SHEET TESTETROL, A NOVEL ORALLY BIOACTIVE ANDROGEN General Pantarhei Bioscience B.V. is an emerging specialty pharmaceutical company with a creative approach towards drug development. The Company
Medications for Prevention and Treatment of Osteoporosis
1 Medications for Prevention and Treatment of Osteoporosis Osteoporosis is a disease where the strength of bones is less than normal, making them more susceptible to fracture, or breaking, than normal
Water Homeostasis. Graphics are used with permission of: Pearson Education Inc., publishing as Benjamin Cummings (http://www.aw-bc.
Water Homeostasis Graphics are used with permission of: Pearson Education Inc., publishing as Benjamin Cummings (http://www.aw-bc.com) 1. Water Homeostasis The body maintains a balance of water intake
Oral Bioavailability of Creatine Supplements: Is There Room for Improvement?
Oral Bioavailability of Creatine Supplements: Is There Room for Improvement? Donald W. Miller Associate Professor Department of Pharmacology and Therapeutics University of Manitoba Acknowledgements ISSN
ENTERAL FORMULAE AND PARENTERAL NUTRITIONAL SOLUTIONS, DME
ENTERAL FORMULAE AND PARENTERAL NUTRITIONAL SOLUTIONS, DME Policy NHP only reimburses participating DME vendors for the provision of medically necessary enteral and parenteral formulae and nutritional
Acid-Base Balance and Renal Acid Excretion
AcidBase Balance and Renal Acid Excretion Objectives By the end of this chapter, you should be able to: 1. Cite the basic principles of acidbase physiology. 2. Understand the bicarbonatecarbon dioxide
Vitamin D. Sources of vitamin D
1 has been in the news frequently this past year, including an article in The New York Times on November 16, 2009. So what is this vitamin? Why is it important? Most people have heard that vitamin D is
